Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff

Background. For the treatment of visceral leishmaniasis in Bangladesh, single dose liposomal amphotericin B (ambisome) is supposed to be the safest and most effective treatment. Specific needs for application and storage raise questions about feasibility of its implementation and acceptance by patie...

Full description

Bibliographic Details
Published in:Journal of Tropical Medicine
Main Authors: Eva-Maria Maintz, Mahbub Hassan, M. Mamun Huda, Debashis Ghosh, Md. Shakhawat Hossain, Abdul Alim, Axel Kroeger, Byron Arana, Dinesh Mondal
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2014
Subjects:
Online Access:https://doi.org/10.1155/2014/676817
https://doaj.org/article/61d8745d0cf643b0912136a54d662188
id ftdoajarticles:oai:doaj.org/article:61d8745d0cf643b0912136a54d662188
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:61d8745d0cf643b0912136a54d662188 2024-09-09T19:26:13+00:00 Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff Eva-Maria Maintz Mahbub Hassan M. Mamun Huda Debashis Ghosh Md. Shakhawat Hossain Abdul Alim Axel Kroeger Byron Arana Dinesh Mondal 2014-01-01T00:00:00Z https://doi.org/10.1155/2014/676817 https://doaj.org/article/61d8745d0cf643b0912136a54d662188 EN eng Wiley http://dx.doi.org/10.1155/2014/676817 https://doaj.org/toc/1687-9686 https://doaj.org/toc/1687-9694 1687-9686 1687-9694 doi:10.1155/2014/676817 https://doaj.org/article/61d8745d0cf643b0912136a54d662188 Journal of Tropical Medicine, Vol 2014 (2014) Arctic medicine. Tropical medicine RC955-962 article 2014 ftdoajarticles https://doi.org/10.1155/2014/676817 2024-08-05T17:48:38Z Background. For the treatment of visceral leishmaniasis in Bangladesh, single dose liposomal amphotericin B (ambisome) is supposed to be the safest and most effective treatment. Specific needs for application and storage raise questions about feasibility of its implementation and acceptance by patients and health staff. Methods. The study was carried out in the most endemic district of Bangladesh. Study population includes patients treated with ambisome or miltefosine, hospital staff, and a director of the national visceral leishmaniasis program. Study methods include direct observation (subdistrict hospitals), open interviews (heath staff and program personnel), structured questionnaires, and focus group discussions (patients). Results. Politicalcommitment for ambisome is strong; the general hospital infrastructure favours implementation but further strengthening is required, particularly for drug storage below 25°C (refrigerators), back-up energy (fuel for generators), and supplies for ambisome administration (like 5% dextrose solution). Ambisome created high satisfaction in patients and hospital staff, less adverse events, and less income loss for patients compared to miltefosine. Conclusions. High political commitment, general capacities of subdistrict hospitals, and high acceptability favour the implementation of ambisome treatment in Bangladesh. However, strengthening of the infrastructure and uninterrupted supplies of essential accessories is mandatory before introducing sLAB in Bangladesh. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Journal of Tropical Medicine 2014 1 7
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Arctic medicine. Tropical medicine
RC955-962
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Eva-Maria Maintz
Mahbub Hassan
M. Mamun Huda
Debashis Ghosh
Md. Shakhawat Hossain
Abdul Alim
Axel Kroeger
Byron Arana
Dinesh Mondal
Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
topic_facet Arctic medicine. Tropical medicine
RC955-962
description Background. For the treatment of visceral leishmaniasis in Bangladesh, single dose liposomal amphotericin B (ambisome) is supposed to be the safest and most effective treatment. Specific needs for application and storage raise questions about feasibility of its implementation and acceptance by patients and health staff. Methods. The study was carried out in the most endemic district of Bangladesh. Study population includes patients treated with ambisome or miltefosine, hospital staff, and a director of the national visceral leishmaniasis program. Study methods include direct observation (subdistrict hospitals), open interviews (heath staff and program personnel), structured questionnaires, and focus group discussions (patients). Results. Politicalcommitment for ambisome is strong; the general hospital infrastructure favours implementation but further strengthening is required, particularly for drug storage below 25°C (refrigerators), back-up energy (fuel for generators), and supplies for ambisome administration (like 5% dextrose solution). Ambisome created high satisfaction in patients and hospital staff, less adverse events, and less income loss for patients compared to miltefosine. Conclusions. High political commitment, general capacities of subdistrict hospitals, and high acceptability favour the implementation of ambisome treatment in Bangladesh. However, strengthening of the infrastructure and uninterrupted supplies of essential accessories is mandatory before introducing sLAB in Bangladesh.
format Article in Journal/Newspaper
author Eva-Maria Maintz
Mahbub Hassan
M. Mamun Huda
Debashis Ghosh
Md. Shakhawat Hossain
Abdul Alim
Axel Kroeger
Byron Arana
Dinesh Mondal
author_facet Eva-Maria Maintz
Mahbub Hassan
M. Mamun Huda
Debashis Ghosh
Md. Shakhawat Hossain
Abdul Alim
Axel Kroeger
Byron Arana
Dinesh Mondal
author_sort Eva-Maria Maintz
title Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
title_short Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
title_full Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
title_fullStr Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
title_full_unstemmed Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
title_sort introducing single dose liposomal amphotericin b for the treatment of visceral leishmaniasis in rural bangladesh: feasibility and acceptance to patients and health staff
publisher Wiley
publishDate 2014
url https://doi.org/10.1155/2014/676817
https://doaj.org/article/61d8745d0cf643b0912136a54d662188
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Journal of Tropical Medicine, Vol 2014 (2014)
op_relation http://dx.doi.org/10.1155/2014/676817
https://doaj.org/toc/1687-9686
https://doaj.org/toc/1687-9694
1687-9686
1687-9694
doi:10.1155/2014/676817
https://doaj.org/article/61d8745d0cf643b0912136a54d662188
op_doi https://doi.org/10.1155/2014/676817
container_title Journal of Tropical Medicine
container_volume 2014
container_start_page 1
op_container_end_page 7
_version_ 1809895873194229760